Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004.

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Obstet Gynecol. 2007 Dec;110(6):1270-8.

PMID:
18055720
2.

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Anesth Analg. 2009 Dec;109(6):1908-15. doi: 10.1213/ANE.0b013e3181c039e6.

PMID:
19923520
3.

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan.

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

Int J Hematol. 2012 Jan;95(1):57-63. doi: 10.1007/s12185-011-0974-9. Epub 2011 Dec 9.

PMID:
22160834
4.

A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.

Franchini M, Franchi M, Bergamini V, Salvagno GL, Montagnana M, Lippi G.

Semin Thromb Hemost. 2008 Feb;34(1):104-12. doi: 10.1055/s-2008-1066022. Review.

PMID:
18393147
5.

Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology.

Murakami M, Kobayashi T, Kubo T, Hata T, Takeda S, Masuzaki H.

J Obstet Gynaecol Res. 2015 Aug;41(8):1161-8. doi: 10.1111/jog.12712. Epub 2015 May 25.

PMID:
26013425
6.

Use of recombinant activated factor VII in massive postpartum haemorrhage.

Bouma LS, Bolte AC, van Geijn HP.

Eur J Obstet Gynecol Reprod Biol. 2008 Apr;137(2):172-7. Epub 2007 Oct 24.

PMID:
17928129
7.

Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.

Jirapinyo M, Manonai J, Herabutya Y, Chuncharunee S.

J Med Assoc Thai. 2007 May;90(5):977-81. Review.

PMID:
17596055
8.

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage.

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

J Obstet Gynaecol Res. 2008 Aug;34(4 Pt 2):623-30. doi: 10.1111/j.1447-0756.2008.00896.x.

PMID:
18840167
9.

[Recombinant activated factor VII in the treatment of life threatening post-partum haemorrhage; registry UniSeven in the Czech Republic].

Seidlová D, Blatný J, Penka M, Ovesná P, Brabec P, Sevcík P, Ventruba P, Cerný V.

Ceska Gynekol. 2010 Aug;75(4):297-305. Czech.

PMID:
20925226
10.

[Our experince with the use of recombinant activated factor VII in postpartum haemorrhage].

Mostić T, Sparić R, Argirović R, Ljubić A, Bozanović T, Arsenijević L, Tomanović-Koković J, Stefanović A.

Srp Arh Celok Lek. 2008 Sep;136 Suppl 3:204-9. Serbian.

11.

Safety and efficacy of recombinant activated factor VII in nonhemophilia children with severe or life-threatening bleeding: a report from the SeveNBleeP registry.

Blatný J, Mathew P, Monagle P, Ovesna P, Fiamoli V.

Blood Coagul Fibrinolysis. 2014 Jun;25(4):326-32. doi: 10.1097/MBC.0000000000000036.

PMID:
24389586
12.

Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).

Segal S, Shemesh IY, Blumenthal R, Yoffe B, Laufer N, Ezra Y, Levy I, Mazor M, Martinowitz U.

Arch Gynecol Obstet. 2003 Oct;268(4):266-7. Epub 2002 Nov 7.

PMID:
14504866
13.

The use of recombinant activated FVII in postpartum hemorrhage.

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Clin Obstet Gynecol. 2010 Mar;53(1):219-27. doi: 10.1097/GRF.0b013e3181cc4378. Review.

PMID:
20142658
14.

Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.

Sobieszczyk S, Breborowicz GH, Platicanov V, Tanchev S, Kessler CM.

Acta Obstet Gynecol Scand. 2006;85(10):1239-47. Review.

PMID:
17068684
15.

Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register.

Isbister J, Phillips L, Dunkley S, Jankelowitz G, McNeil J, Cameron P.

Intern Med J. 2008 Mar;38(3):156-65. Epub 2007 Oct 3.

PMID:
17916172
16.

[Recombinant activated factor VII as a life-saving therapy for severe postpartum haemorrhage unresponsive to conservative traditional management].

Brice A, Hilbert U, Roger-Christoph S, Fernandez H, Dumenil AS, Descorps-Declère A, Mercier F, Benhamou D.

Ann Fr Anesth Reanim. 2004 Nov;23(11):1084-8. French.

PMID:
15581725
17.

Use of recombinant activated factor VII in severe post-partum haemorrhage: data from the Italian Registry: a multicentric observational retrospective study.

Barillari G, Frigo MG, Casarotto M, Farnia A, Massè B, Wetzl R, Bianchin A, Rabi A, Malacarne P, Pasca S, Bigotto E; Italian rFVIIa-PPH Study Group.

Thromb Res. 2009 Dec;124(6):e41-7. doi: 10.1016/j.thromres.2009.08.018. Epub 2009 Sep 24.

PMID:
19783283
18.

[Off-label use of recombinant factor VII (rFVIIa) in teaching hospitals in Paris in 2010].

Bardon J, Fink J, de Montblanc J, Bergmann JF, Sarrut B, Benhamou D.

Ann Fr Anesth Reanim. 2013 Oct;32(10):659-64. doi: 10.1016/j.annfar.2013.05.007. Epub 2013 Aug 13. French.

PMID:
23953834
19.

The use of recombinant activated factor VII in trauma patients: Experience from the Australian and New Zealand haemostasis registry.

Cameron P, Phillips L, Balogh Z, Joseph A, Pearce A, Parr M, Jankelowitz G.

Injury. 2007 Sep;38(9):1030-8. Epub 2007 Aug 15. Erratum in: Injury. 2008 Jan;39(1):138-9.

PMID:
17706654
20.

Pulmonary embolism after administration of recombinant activated Factor VII for major obstetric hemorrhage.

McCarthy GC, Allen TK, Habib AS.

J Clin Anesth. 2012 Sep;24(6):508-9. doi: 10.1016/j.jclinane.2011.09.004. No abstract available.

PMID:
22986324

Supplemental Content

Support Center